A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults - Concepedia

Concepedia

Publication | Open Access

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults

DOI Full Paper Access

40

Citations

13

References

2015

Year

Sharon R. Sheehan, Stephanie A. Harris, Iman Satti, David A. Hokey, Veerabadran Dheenadhayalan, Lisa Stockdale, Zita‐Rose Manjaly Thomas, Alice Minhinnick, Morven Wilkie, Samantha Vermaak,

Abstract

ClinicalTrials.gov NCT01683773.

References

	Year	Citations

Page 1